The Present and Future of Allergen Immunotherapy in Personalized Medicine

Dear Colleagues,

Allergen immunotherapy is a medical treatment for allergies. It is a disease-modifying therapy, indicated for the treatment of allergic rhinitis, allergic conjunctivitis, allergic asthma, and Hymenoptera hypersensitivity. Allergen immunotherapy can be administered either subcutaneously in a physician’s office or sublingually by a patient at home. Oral immunotherapy is used in food allergies. In addition, several biologics that control specific responsible molecules and directly suppress allergic reactions have recently become available. Even in the current era, the significance of allergen immunotherapy, which modifies the natural history of allergic diseases, seems to be prominent.

This Special Issue aims to highlight the role of personalized medicine in clinical practice, providing a complete overview of allergen immunotherapy and highlighting the critical issues in its management. We welcome the submission of original papers and reviews regarding allergen immunotherapy for allergic diseases.

Prof. Dr. Giorgio Walter Canonica
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.